Skip to main content

Propylthiouracil-induced agranulocytosis complicated by severe infection in a patient with Graves’ disease: A case report Cover

.blurhash-client-img { display: none !important; }

Propylthiouracil-induced agranulocytosis complicated by severe infection in a patient with Graves’ disease: A case report

Endocrine Regulations

Volume 59 (2025): Issue 1 (January 2025)

By: Jens Skjoldan Svenningsen and Djordje Marina

Open Access

|Nov 2025

Authors

Jens Skjoldan Svenningsen

Department of Endocrinology, Amager and Hvidovre Hospital, Hvidovre, Denmark

Djordje Marina

dorde.marina.02@regionh.dk

Department of Endocrinology, Amager and Hvidovre Hospital, Hvidovre, Denmark

Articles in this issue

DOI: https://doi.org/10.2478/enr-2025-0022 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 195 - 198

Published on: Nov 10, 2025

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

Graves’ disease,

anti-thyroid treatment,

propylthiouracil,

agranulocytosis,

granulocyte colony-stimulating factor,

potassium iodine,

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2025 Jens Skjoldan Svenningsen, Djordje Marina, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 59 (2025): Issue 1 (January 2025)

Previous article